Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib
Lipsky, A. H., Farooqui, M. Z. H., Tian, X., Martyr, S., Cullinane, A. M., Nghiem, K., Sun, C., Valdez, J., Niemann, C. U., Herman, S. E. M., Saba, N., Soto, S., Marti, G., Uzel, G., Holland, S. M., LVolume:
100
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2015.126672
Date:
December, 2015
File:
PDF, 1.66 MB
english, 2015